CD40 agonistic monoclonal antibody APX005M (sotigalimab) and chemotherapy, with or without nivolumab, for the treatment of metastatic pancreatic adenocarcinoma: an open-label, multicentre, phase 1b study - The Lancet Oncology
CD40 Bioassay
Frontiers | CD40L and Its Receptors in Atherothrombosis—An Update
First‐in‐human study with intratumoral administration of a CD40 agonistic antibody, ADC‐1013, in advanced solid malignancies - Irenaeus - 2019 - International Journal of Cancer - Wiley Online Library
CD40: Targeting Co-Stimulatory Pathways for Cancer Immunotherapy
Dendritic cell targeting with Fc-enhanced CD40 antibody agonists induces durable antitumor immunity in humanized mouse models of bladder cancer | Science Translational Medicine
Anti-CD40 antibody KPL-404 inhibits T cell-mediated activation of B cells from healthy donors and autoimmune patients | Arthritis Research & Therapy | Full Text
Assessment of the anti-CD40 antibody iscalimab in patients with primary Sjögren's syndrome: a multicentre, randomised, double-blind, placebo- controlled, proof-of-concept study - The Lancet Rheumatology
model of the potential effects of agonist anti-CD40 on the T-cell... | Download Scientific Diagram
With the High Potential in Cancer Immunotherapy, CD40 Is Triggering Attention - Cusabio
Anti-CD40 antibody KPL-404 inhibits T cell-mediated activation of B cells from healthy donors and autoimmune patients | Arthritis Research & Therapy | Full Text
Therapeutic Activity of Agonistic, Human Anti-CD40 Monoclonal Antibodies Requires Selective FcγR Engagement - ScienceDirect
Novel combination immunotherapy for pancreatic cancer: potent anti‐tumor effects with CD40 agonist and interleukin‐15 treatment - Van Audenaerde - 2020 - Clinical & Translational Immunology - Wiley Online Library
Line-selective macrophage activation with an anti-CD40 antibody drives a hemophagocytic syndrome in mice - ScienceDirect
Anti-CD40 agonistic antibody eradicates tumor and induces transient... | Download Scientific Diagram
CD40
Anti-CD40 Antibody - Pipeline Insight, 2022
Anti-CD40 clinical trials* against pancreatic cancer | Download Table
Next-IO™ Anti-CD40 Therapeutic Monoclonal Antibody Program - Creative Biolabs
Side effects of CD40 agonistic antibodies versus fusion molecules. | Download Scientific Diagram
IJMS | Free Full-Text | FcγRs and Their Relevance for the Activity of Anti-CD40 Antibodies
The Parker Institute for Cancer Immunotherapy and the Cancer Research Institute Announce First Patients Treated in Pancreatic Cancer Clinical Trial Combining Immunotherapy and Chemotherapy - Parker Institute for Cancer Immunotherapy
CD40 stimulation as a molecular adjuvant for cancer vaccines and other immunotherapies | Cellular & Molecular Immunology
Frontiers | Next Generation CD40 Agonistic Antibodies for Cancer Immunotherapy
Frontiers | Next Generation CD40 Agonistic Antibodies for Cancer Immunotherapy
Cancers | Free Full-Text | Agonistic CD40 Antibodies in Cancer Treatment
![PDF] Agonistic CD40 Antibodies and Cancer Therapy | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/7cb235318895039cd45eb055391de568e99105c1/2-Table1-1.png "PDF] Agonistic CD40 Antibodies and Cancer Therapy | Semantic Scholar")
PDF] Agonistic CD40 Antibodies and Cancer Therapy | Semantic Scholar
